Skip to main content

Table 2 Influence of group on “STEO sway path (mm) at T1” based on the regression analysis

From: It’s never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial

Model including as additional covariates Estimated group difference for STEO sway path (mm) at T1 95% CI P
Primary analysis model (ITT) including
 STEO sway path at T0 34.5 -30.0 – 100.9 0.279
Sensitivity analysis model including additionally
 Patients’ age 30.4* -38.1 – 98.8 0.088
 Therapy-free time until study inclusion 27.9* -36.2 – 91.9 0.384
Per-protocol analysis model including
 STEO sway path at T0 32.5* -41.1 – 106.0 0.376
  1. Regression analysis according to the intention-to-treat- (n = 41) and per-protocol principle (n = 37); independent variable: group; dependent variable: “STEO sway path (mm) at T1”; *adjusted for STEO sway path at T0
  2. Abbreviations: STEO semi-tandem stance with eyes open, CI confidence interval